These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 37658014

  • 1. Long-term beneficial effects of mirabegron in pediatric patients with therapy-refractory neurogenic lower urinary tract dysfunction.
    van Veen FEE, Schotman M, 't Hoen LA, Blok BFM, Scheepe JR.
    J Pediatr Urol; 2023 Dec; 19(6):753.e1-753.e8. PubMed ID: 37658014
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of Mirabegron as adjuvant treatment in children with refractory neurogenic bladder dysfunction.
    Sager C, Sanmartino M, Burek C, Gomez YR, Vazquez Patiño M, Weller S, Ruiz J, Lopez Imizcoz F, Tessi C, Szklarz T, Corbetta JP.
    J Pediatr Urol; 2020 Oct; 16(5):655.e1-655.e6. PubMed ID: 32800710
    [Abstract] [Full Text] [Related]

  • 3. Intradetrusor onabotulinum-a toxin injections in children with therapy-resistant idiopathic detrusor overactivity. A retrospective study.
    Ringoir A, Dhondt B, De Bleser E, Van Laecke E, Everaert K, Groen LA, Hoebeke P, Spinoit AF.
    J Pediatr Urol; 2020 Apr; 16(2):181.e1-181.e8. PubMed ID: 31964616
    [Abstract] [Full Text] [Related]

  • 4. Factors predicting the success of intradetrusor onabotulinum toxin-A treatment in children with neurogenic bladders due to myelomeningocele: The outcomes of a large cohort.
    Danacioglu YO, Keser F, Ersoz C, Polat S, Avci AE, Kalkan S, Silay MS.
    J Pediatr Urol; 2021 Aug; 17(4):520.e1-520.e7. PubMed ID: 33712371
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Botulinum injection is useless on fibrotic neuropathic bladders.
    Tiryaki S, Yagmur I, Parlar Y, Ozel K, Akyildiz C, Avanoglu A, Ulman I.
    J Pediatr Urol; 2015 Feb; 11(1):27.e1-4. PubMed ID: 25448589
    [Abstract] [Full Text] [Related]

  • 7. Urodynamic Outcomes in Children after Single and Multiple Injections for Overactive and Low Compliance Neurogenic Bladder Treated with Abobotulinum Toxin A.
    Naqvi S, Clothier J, Wright A, Garriboli M.
    J Urol; 2020 Feb; 203(2):413-419. PubMed ID: 31518199
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acute effect of sacral neuromodulation on video-urodynamic parameters of neurogenic lower urinary tract dysfunction in a patient with vesicoureteral reflux: a case report.
    Meng L, Tian Z, Wang M, Liu X, Ma T, Wang J, Zhang W, Zhang Y.
    Ann Palliat Med; 2022 Apr; 11(4):1568-1574. PubMed ID: 35523758
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A pilot prospective study to evaluate whether the bladder morphology in cystography and/or urodynamic may help predict the response to botulinum toxin a injection in neurogenic bladder refractory to anticholinergics.
    Álvares RA, Araújo ID, Sanches MD.
    BMC Urol; 2014 Aug 14; 14():66. PubMed ID: 25123234
    [Abstract] [Full Text] [Related]

  • 13. A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction.
    Welk B, Hickling D, McKibbon M, Radomski S, Ethans K.
    Neurourol Urodyn; 2018 Nov 14; 37(8):2810-2817. PubMed ID: 30168626
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prospective Pilot Study of Mirabegron in Pediatric Patients with Overactive Bladder.
    Blais AS, Nadeau G, Moore K, Genois L, Bolduc S.
    Eur Urol; 2016 Jul 14; 70(1):9-13. PubMed ID: 26876327
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.